ID: ALA3105674

Max Phase: Preclinical

Molecular Formula: C26H22N2O4S2

Molecular Weight: 490.61

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCS(=O)(=O)c1ccc(CC(=O)Nc2nc(-c3ccccc3)c(C(=O)c3ccccc3)s2)cc1

Standard InChI:  InChI=1S/C26H22N2O4S2/c1-2-34(31,32)21-15-13-18(14-16-21)17-22(29)27-26-28-23(19-9-5-3-6-10-19)25(33-26)24(30)20-11-7-4-8-12-20/h3-16H,2,17H2,1H3,(H,27,28,29)

Standard InChI Key:  MDMLFHGEDDZHNU-UHFFFAOYSA-N

Associated Targets(Human)

Nuclear receptor ROR-gamma 8495 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nuclear receptor ROR-beta 600 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nuclear receptor ROR-alpha 562 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nuclear receptor ROR-gamma 89407 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 490.61Molecular Weight (Monoisotopic): 490.1021AlogP: 5.02#Rotatable Bonds: 8
Polar Surface Area: 93.20Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.81CX Basic pKa: CX LogP: 5.36CX LogD: 5.23
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.35Np Likeness Score: -1.74

References

1. Wang Y, Cai W, Zhang G, Yang T, Liu Q, Cheng Y, Zhou L, Ma Y, Cheng Z, Lu S, Zhao YG, Zhang W, Xiang Z, Wang S, Yang L, Wu Q, Orband-Miller LA, Xu Y, Zhang J, Gao R, Huxdorf M, Xiang JN, Zhong Z, Elliott JD, Leung S, Lin X..  (2014)  Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.,  22  (2): [PMID:24388993] [10.1016/j.bmc.2013.12.021]
2. Gege C, Schlüter T, Hoffmann T..  (2014)  Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.,  24  (22): [PMID:25305688] [10.1016/j.bmcl.2014.09.053]
3. Fauber BP, Magnuson S..  (2014)  Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).,  57  (14): [PMID:24502334] [10.1021/jm401901d]
4. Wang Y, Cai W, Tang T, Liu Q, Yang T, Yang L, Ma Y, Zhang G, Huang Y, Song X, Orband-Miller LA, Wu Q, Zhou L, Xiang Z, Xiang JN, Leung S, Shao L, Lin X, Lobera M, Ren F..  (2018)  From RORγt Agonist to Two Types of RORγt Inverse Agonists.,  (2): [PMID:29456799] [10.1021/acsmedchemlett.7b00476]

Source